USD 7.04
(1.15%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 1.66 Billion USD | -34.42% |
2022 | 2.53 Billion USD | 22.61% |
2021 | 2.07 Billion USD | 206.74% |
2020 | 675.15 Million USD | -3.18% |
2019 | 697.31 Million USD | 0.0% |
2001 | 2.53 Billion USD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 1.62 Billion USD | 2.75% |
2024 Q1 | 1.58 Billion USD | -5.02% |
2023 FY | 1.66 Billion USD | -34.42% |
2023 Q4 | 1.66 Billion USD | -17.82% |
2023 Q2 | 2.29 Billion USD | -5.18% |
2023 Q1 | 2.41 Billion USD | -4.81% |
2023 Q3 | 2.02 Billion USD | -11.59% |
2022 Q4 | 2.53 Billion USD | 35.74% |
2022 Q3 | 1.87 Billion USD | -6.19% |
2022 Q2 | 1.99 Billion USD | -3.09% |
2022 FY | 2.53 Billion USD | 22.61% |
2022 Q1 | 2.05 Billion USD | -0.64% |
2021 Q1 | 1.72 Billion USD | 155.95% |
2021 FY | 2.07 Billion USD | 206.74% |
2021 Q4 | 2.07 Billion USD | -3.7% |
2021 Q3 | 2.15 Billion USD | 24.6% |
2021 Q2 | 1.72 Billion USD | -0.12% |
2020 FY | 675.15 Million USD | -3.18% |
2020 Q1 | - USD | 0.0% |
2020 Q4 | 675.15 Million USD | 0.0% |
2019 FY | 697.31 Million USD | 0.0% |
2001 FY | 2.53 Billion USD | 0.0% |
2001 Q4 | 2.07 Billion USD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
ADC Therapeutics SA | 354.78 Million USD | -369.399% |
Alto Neuroscience, Inc. | 86.62 Million USD | -1822.406% |
Annovis Bio, Inc. | 10.2 Million USD | -16213.665% |
Biohaven Pharmaceutical Holding Company Ltd. | 513.21 Million USD | -224.494% |
Nuvation Bio Inc. | 621.48 Million USD | -167.962% |
Nuvation Bio Inc. | 621.48 Million USD | -167.962% |
Arcus Biosciences, Inc. | 1.09 Billion USD | -52.086% |
Zymeworks Inc. | 580.88 Million USD | -186.693% |